Skip to main content
Spring 2025 DC Public Health Priorities Requirement
Not Found
Webinar

S25-401 Medications for Opioid Use Disorder (MOUD): Considerations for Effective Interdisciplinary Care

Total Credits: 3 Category I CEs

Bundle(s):
Spring 2025 DC Public Health Priorities Requirement
Categories:
400 Substance Use Disorders |  DC Public Health Priorities
Instructor:
Bernard Showers, DSW, LCSW
Course Levels:
Intermediate
Duration:
3 Hours 15 Minutes
Target Audience:
Social Workers, LCPCs, and Psychologists
Dates
Save for Later  Add to Cart »

Description

The Medications in the Treatment of Opioid Use Disorders (MOUD) workshop is a three-hour, non-medical workshop aimed at improving interdisciplinary care considerations for clients receiving or considering medications in the treatment of opioid use disorder (OUD). Basic information on common medications used in the treatment of OUD, including buprenorphine, methadone, and naltrexone, will be covered. Best practice approaches for coordinating with prescribers, supporting the client's whole-person recovery efforts including OUD, and helping clients through advocacy and support for clients in coping with bias and discrimination will be reviewed.   

 

This workshop is in accordance and compliance with the NASW standards with a focus on the principles of service, dignity and worth of the person, importance of human relationships, and competence; and the standard of responsibilities to clients, as professionals, and to the social work profession.

Maryland: This workshop is in compliance with the Maryland Board of Social Work Examiners’ COMAR 10.42.03.06.A(5).

District of Columbia: This workshop is in compliance with the District of Columbia Board of Social Work 17-70-7008.4 and meets the continuing education requirement for DC Public Health Priorities in the following topic: 1. Responsible opioid prescribing and effective pain management.

Instructor

Bernard Showers, DSW, LCSW Related Seminars and Products

Dr. Bernard Showers, DSW, LCSW, earned his MSW at Shippensburg University in 2010. He is currently employed as an adjunct professor with several universities, including University of Kentucky, University of Maryland, and Simmons University. Bernard has over ten years of experience as a licensed social worker. He provides therapy for various ages and presenting problems; however, he specializes in treating substance use disorders, co-occurring disorders, anxiety, and depression. He employs an eclectic approach to therapy by utilizing various evidence-based practices, including motivational interviewing, cognitive behavioral therapy, and acceptance and commitment therapy.    

He is currently one of approximately 1,500 Motivational Interviewing Network of Trainers (MINT) members worldwide. Mr. Showers has trained aspiring and active independent practitioners at many colleges, universities, governmental agencies, and companies around the United States. In addition to motivational interviewing, Mr. Showers has developed, presented, and published several continuing education workshops on family involvement in substance use treatment, ASAM criteria cognitive Behavioral Therapy, and group therapy. The Beck Institute has also trained Mr. Showers in cognitive behavioral therapy.    

Bernard is a graduate of the inaugural class of The University of Kentucky's Doctorate of Social Work (DSW) Program. In July 2021, Bernard Showers was the lead author on the manuscript “Medication for opioid use disorder in rural America: A review of the literature,” published in the APA's Journal of Rural Mental Health. He is passionate about bringing awareness and solutions to enhance social work students’ preparedness in meeting the nation’s micro-, mezzo-, and macro-level substance use needs, as examined in his doctoral capstone project, Substance use education in social work programs: Time for a mandate?    

Agenda & Learning Objectives

AGENDA:

12:50 pm – 1:00 pm Log on  

1:00 pm – 1:45 pm Introduction to MOUD  

  • Medication Overview  

  • History of MOUD  

  • Challenges with Access to MOUD  

  • The American Opioid Epidemic  

1:45 pm – 2:30 pm Medications   

  • Methadone   

  • Buprenorphine  

  • Naltrexone  

2:30 pm  - 2:45 pm BREAK  

2:45 pm – 4:00 pm Interdisciplinary Care  

  • Historical Considerations   

    • Stigma  

    • Harm reduction approaches  

  • Creating A Supportive Treatment Environment  

  • Communication Between Providers    

 4:00 pm – 4:15 Resources  

  • Current evidence on efficacy of MOUD  

  • Review of Local, State, and National Resources              

 4:15 Adjournment  

 

LEARNING OBJECTIVES:

Upon the completion of this workshop, participants will be able to:

  • Describe the major differences between medications commonly used in treatment of OUD.  

  • Create a supportive environment for clients receiving MOUD.        

  • Discuss the efficacy of MOUD.  

  • Identify local, state, and federal resources to support their clients receiving MOUD.  

Bibliography & References

BIBLIOGRAPHY & REFERENCES

JMC. (2021). AJMC. https://www.ajmc.com/view/an-overview-of-medication-assisted-treatment-for-opioid-and-alcohol-use-disorders 

Anddrilla, H.C., Coulthard, C., & Patterson, D. G. (2018a). Prescribing practices of rural physicians waivered to prescribe Buprenorphine. American Journal of Preventive Medicine, 54(6), S208-S214. https://doi.org/10.1016/j.ampre.2018.02.006 

Anddrilla, H.C., Moore, T.E., & Patterson, D.G., & Larson,E.H. (2018b) Geographic distribution of providers with a DEA waiver to prescribe Buprenorphine for the treatment of Opioid Use Disorder: A 5‐year update. The Journal of Rural Health, 35(6),108-112. https://doi-org.ezproxy.uky.edu/10.1111/jrh.12307 

Centers for Disease Prevention and Control. (2019). Annual surveillance report of drug-related risks and outcomes. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf 

Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., &Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9), 1– 171. DOI: 10.3310/hta11090 

Council of Economic Advisors. (2017). The underestimated cost of the opioid rises.  https://www.whitehouse.gov/sites/whitehouse.gov/files/images/The%20Underestimated%20Cost%20of%20the%20Opioid%20Cris.pdf. 

CQ Researcher. (2020). Issues for debate in social policy. (3rd ed.) Sage Press. 

Edmond, M.B., Aletraris, L., & Roman, P.M. (2015). Rural substance treatment centers in the United States: An assessment of treatment quality by location. American Journal of Drug and Alcohol Abuse, 41(5), 449-457. doi: 10.3109/00952990.2015.1059842 

Hancock, C., Mennenga,H., King, N., Andrilla, H.C., Larson, E.H., Schou, P. (2017) Treating the rural opioid epidemic. National Rural Health  Association. https://www.ruralhealthweb.org/NRHA/media/Emerge_NRHA/Advocacy/Policy%20documents/Treatingthe-Rural-Opioid-Epidemic_Feb-2017_NRHA-PolicyPaper.pdf.  

Kelly, J.F., Dow, S.J., & Westerhoff, C. (2010). Does our choice of substance-related terms influence perceptions of treatment need?  An empirical investigation with two commonly used terms. Journal of Drug Issues, 40(4), 805-818. 

Moody, L. N., Satterwhite, E., & Bickel, W.K. (2017). Substance use in rural Central Appalachia: Current status and treatment considerations. Journal of Rural Mental Health, 41(2), 123-125. https://doiorg.proxyhs.researchreport.umd.edu/10.1037/rmh0000064 

SAMHSA (2022). Harm reduction. SAMHSA. https://www.samhsa.gov/find-help/harm-reduction 

SAMHSA. (2021) TIP 63: Medications for Opioid Use Disorder. SAMHSA.  https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP21-02-01-002 

Siegel, J. (2019). Rural hospital closures rise to ninety-eight. Rural Health Voices. National Rural Health Association. https://www.ruralhealthweb.org/blogs/ruralhealthvoices/february-2019/rural-hospital-closures-rise-to-ninety-seven 

United States Department of Health and Human Services. (2020, September 19). Opioid  crisis statistics. HHS.  https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html 

Volkow ND, Frieden TR, Hyde PS, Cha SS. (2014) Medication-assisted therapies--Tackling the opioid overdose epidemic. New England Journal of Medicine.370(22), 2063-2066. doi:10.1056/NEJMp1402780. 

Wakeman, S.E., & Rich, J.D. (2018) Barriers to medications for addiction treatment: How stigma kills, Substance Use & Misuse, 53(2), 330-333. DOI: 10.1080/10826084.2017.1363238 

Wilkerson, R.G., Hong, K.K., Windsor, T.A., & Mareiniss, D.P. (2016). The opioid epidemic in the United States. Emergency Medical Clinics of North America. 34(2), https://www-clinicalkey-com.ezproxy.uky.edu/#!/content/playContent/1-s2.0-S073386271500108X?returnurl=null&referrer=null 

 

Course Completion & CE Information

Category I Maryland BSWE Requirement

The Office of Continuing Professional Education at the University Of Maryland School Of Social Work is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs. This workshop qualifies for 3 Category I Continuing Education Units. The Office of Continuing Professional Education is also authorized by the Maryland Board of Psychologists and the Maryland Board of Professional Counselors to sponsor Category A continuing professional education.


Please refer to the tab "Live Interactive Webinar Policies & FAQs" for UMSSW Office of CPE policies regarding all live interactive webinar related matters.

Evaluation

Participants will have access to the evaluation after attendance has been verified. Evaluations will be available for one (1) week after the workshop has ended.  

After one (1) week, participants will no longer have access to the evaluation and will have to contact CPE about reactivation.

Target Audience

Social Workers, LCPCs, and Psychologists

We welcome anyone interested in the topic!

 

Late Fees and Refunds

The base price is $70, which includes CE credit.  

Late Fee: On 7/10/25, a non-refundable late fee of $20 is added to the base price. Late fees cannot be refunded or applied to account credit.  

Cancellations: **ALL cancellations will be subjected to a $35.00 administration fee.**  To be eligible for a refund or CPE account credit, cancellations must be made at least 24 hours before the workshop. 

For more information, please read the general policies on our website.  

 

Live Interactive Webinar Platforms

LIVE INTERACTIVE WEBINAR PLATFORMS

The Office of Continuing Professional Education hosts Live Interactive Webinars through Zoom. This platform offers a high quality and user-friendly webinar platform for our registrants.

System Requirements:

  • Operating Systems: Windows XP or higher; MacOS 9 or higher; Android 4.0 or higher.
  • Internet Browser: Google Chrome; Firefox 10.0 or higher.

Our system is not compatible with the Safari web browser.

  • Broadband Internet Connection: Cable, High-speed DSL and any other medium that is internet accessible.

**Please have your device charging at all times to ensure that your device does not lose power during the webinar.

Course Interaction Requirements:

To participate in Live Interactive Webinars, you MUST have a device that allows you to view the presentation on screen and hear the instructor at all times. We do not allow participants to call-in from their phones or mobile devices and solely listen to the presentation. Participation in Live Interactive Webinars is mandatory.

Our webinar policies can be found on our website by clicking here.

Webinar Policies & FAQs

Click The Link to View The Webinar Policies & FAQs

https://umbsswcpe.ce21.com/Page/live-interactive-webinar-procedures-policies-4129

 

 

Code of Conduct

The Office of Continuing Professional Education at the University of Maryland School of Social Work adheres to the NASW Code of Ethics. This policy is to ensure that the training environment for social work professionals remains respectful, productive, and conducive to learning. Disruptive behavior that interferes with the learning process, disrupts the training experience for others, or undermines the integrity of the program will not be tolerated.

 

Expectations for Participant Engagement:

In alignment with the NASW Code of Ethics and the University of Maryland Baltimore Code of Conduct, participants are expected to demonstrate professionalism, which includes respecting confidentiality, maintaining a collaborative and respectful tone, and contributing positively to the group dynamic. Disclosures made during the training (e.g., case studies or personal reflections) must be handled with care and in accordance with ethical and legal guidelines.

All participants in the training program are expected to:

  • Engage actively in the learning process and show respect for the opinions and contributions of others.
  • Demonstrate professionalism in both attitude and behavior, maintaining respect for instructors, peers, and the training environment.
  • Maintain open communication by expressing concerns or disagreements constructively and respectfully.
  • Follow the guidelines and expectations provided by instructors and facilitators.
  • Support a collaborative learning environment where all participants feel valued and safe to contribute.

 

Instructors and CPE staff reserve the right to dismiss participants who do not adhere to ethical/professional principles and standards. If removed, CEs will be adjusted to reflect the time attended, unless otherwise specified. 

ADA Accommodations

If you are requesting ADA accommodations, please contact our office via email at least two weeks prior to the workshop date. Requests after that date may not be fulfilled.  

Our email address is cpe@ssw.umaryland.edu.  

Back to Top